FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2008
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

NOEL DAVID M 		2. Issuer Name and Ticker or Trading Symbol

LIFECORE BIOMEDICAL INC [ LCBM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CFO & VP of Finance
(Last)          (First)          (Middle)

3515 LYMAN BOULEVARD 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/20/2008
(Street)

CHASKA, MN 55318
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/20/2008     U    8618   D $17.00   0   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   $9.45                     (1) 2/18/2012   Common Stock   5000     5000   D    
Stock Option (Right to Buy)   $7.31                     (1) 3/3/2013   Common Stock   1000     6000   D    
Stock Option (Right to Buy)   $8.10                     (1) 3/3/2014   Common Stock   30000     36000   D    
Stock Option (Right to Buy)   $5.91                     (1) 6/23/2014   Common Stock   30000     66000   D    
Stock Option (Right to Buy)   $12.74                     (2) 8/10/2017   Common Stock   17500     83500   D    

Explanation of Responses:
( 1)  100% exercisable.
( 2)  In connection with the February 21, 2008 commencement of the tender offer to purchase all the outstanding common stock of Lifecore at $17.00 per share, all of the outstanding stock options became fully vested and exercisable in their entirety on that date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
NOEL DAVID M
3515 LYMAN BOULEVARD
CHASKA, MN 55318

CFO & VP of Finance

Signatures
/s/ David Noel 3/24/2008
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.
Lifecore Biomedical (MM) (NASDAQ:LCBM)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Lifecore Biomedical (MM) Charts.